GlassScriptPhysician profile
Carla Watase
NPI 1811432784
$4,714.34
in general payments reported to CMS, 2019-2025
15 companies · $1,020 in 2025
The $1,020 reported for 2025 was more than what 91% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $55.08 · 2021: $1,059 · 2022: $707 · 2023: $659 · 2024: $1,214 · 2025: $1,020.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,893.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,893.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $1,386.31 | 2022-2025 | Infuse, Biotrue One Day, Infuse Multifocal |
| Sun Pharmaceutical Industries INC. | $864.65 | 2021-2025 | Cequa, Xelpros |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $475.97 | 2021 | |
| Alcon Vision LLC | $336.69 | 2021-2024 | Total30, Rocklatan, Hydrus Microstent |
| Glaukos Corporation | $332.68 | 2024-2025 | Photrexa Viscous and Photrexa, Photrexa |
| Tarsus Pharmaceuticals, INC. | $292.45 | 2024-2025 | Xdemvy |
| Aerie Pharmaceuticals, INC. | $266.60 | 2020-2021 | |
| Coopervision INC. | $190.68 | 2023-2025 | Myday Contact Lens, Clariti Contact Lens |
| Horizon Therapeutics Plc | $176.00 | 2022-2023 | Tepezza |
| Ivantis, INC | $126.28 | 2021 | |
| Johnson & Johnson Vision Care, INC. | $76.17 | 2023-2024 | Acuvue |
| Kala Pharmaceuticals, INC. | $75.70 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $50.88 | 2021-2022 | |
| Eyevance Pharmaceuticals LLC | $36.15 | 2020-2021 | |
| Allergan, INC. | $27.13 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carla Watase listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.